31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy

Journal of Neurology

Volumn 254, Issue 1, 2007, Pages 29-37

  Jeppesen, Tina Dysgaard ^a   Quistorff, Bjørn ^b   Wibrand, Flemming ^c   Vissing, John ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c JOHN F KENNEDY INSTITUTE   (Denmark)

Author keywords

31 Phosphorous magnetic resonance spectroscopy muscle disorders; Diagnostic procedures; Mitochondrial myopathy; mtDNA mutations

Indexed keywords

ADENOSINE TRIPHOSPHATE; CITRATE SYNTHASE; LACTIC ACID; MITOCHONDRIAL ENZYME; OXYGEN; PHOSPHORUS 31; MITOCHONDRIAL DNA; PHOSPHORUS; SUCCINATE DEHYDROGENASE (UBIQUINONE);

ADULT; ARM MUSCLE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME ACTIVITY; FEMALE; GENE DELETION; HAND GRIP; HUMAN; LACTATE BLOOD LEVEL; LEG MUSCLE; MALE; MITOCHONDRIAL MYOPATHY; NEUROLOGIC EXAMINATION; OXYGEN CONSUMPTION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POINT MUTATION; PRIORITY JOURNAL; SKELETAL MUSCLE; SYMPTOM; VENOUS OXYGEN TENSION; AGED; BLOOD; EXERCISE; EXERCISE TEST; GENETICS; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPECTROSCOPY;

ADULT; AGED; CITRATE (SI)-SYNTHASE; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX II; EXERCISE; EXERCISE TEST; FEMALE; HAND STRENGTH; HUMANS; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MITOCHONDRIAL MYOPATHIES; MUSCLE, SKELETAL; PHOSPHORUS ISOTOPES; SPECTRUM ANALYSIS;

EID: 33847095419     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0229-5     Document Type: Article

References (41)

1. Argov Z, Bank WJ, Maris J, Peterson P, Chance B (1987) Bioenergetic heterogeneity of human mitochondrial myopathies: phosphorus magnetic resonance spectroscopy study. Neurology 37:257-262
2. Argov Z, Bank WJ (1991) Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders. Ann Neurol 30:90-97
3. Argov Z, De Stefano N, Arnold DL (1996) ADP recovery after a brief ischemic exercise in normal and diseased human muscle-a 31P MRS study. NMR Biomed 9:165-172
4. Arnold DL, Taylor DJ, Radda GK (1985) Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 18:189-196
5. Bangsbo J, Johansen L, Quistorff B, Saltin B (1993) NMR and analytical biochemical evaluation of PCr and nucleotides in the human calf muscle during contraction. J Appl Physiol 74:2034-2039
6. Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR (2002) Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 59:1406-1411
7. Chen JT, Taivassalo T, Argov Z, Arnold DL (2001) Modeling in vivo recovery of intracellular pH in muscle to provide a novel index of proton handling: application to the diagnosis of mitochondrial myopathy. Magn Reson Med 46:870-878
8. Ciafaloni E, Ricci E, Shanske S, Moraes CT, Silvestri G, Hirano M, Simonetti S, Angelini C, Donati MA, Garcia C (1992) MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 31:391-398
9. Dimauro S, Tay S, Mancuso M (2004) Mitochondrial encephalomyopathies: diagnostic approach. Ann N Y Acad Sci 1011:217-231
10. Hoch JC, Stern AS (1995) NMR data processing. Wiley-Liss, New York
11. Janssen AJ, Smeitink JA, van den Heuvel LP (2003) Some practical aspects of providing a diagnostic service for respiratory chain defects. Ann Clin Biochem 40:3-8
12. Jensen TD, Kazemi-Esfarjani P, Skomorowska E, Vissing J (2002) A forearm exercise screening test for mitochondrial myopathy. Neurology 58:1533-1538
13. Jeppesen TD, Olsen D, Vissing J (2003) Cycle ergometry is not a sensitive diagnostic test for mitochondrial myopathy. J Neurol 250:293-299
14. Johnston W, Karpati G, Carpenter S, Arnold D, Shoubridge EA (1995) Late-onset mitochondrial myopathy. Ann Neurol 37:16-23
15. Katz SD, Bleiberg B, Wexler J, Bhargava K, Steinberg JJ, LeJemtel TH (1993) Lactate turnover at rest and during submaximal exercise in patients with heart failure. J Appl Physiol 75:1974-1979
16. Kemp GJ, Taylor DJ, Thompson CH, Hands LJ, Rajagopalan B, Styles P, Radda GK (1993) Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise. NMR Biomed 6:302-310
17. Krause KH, Bonjour JP, Berlit P, Kochen W (1985) Biotin status of epileptics. Ann N Y Acad Sci 447:297-313
18. Krentz AJ, Coles NH, Williams AC, Nattrass M (1990) Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy. Metabolism 39:938-942
19. Kuhl CK, Layer G, Traber F, Zierz S, Block W, Reiser M (1994) Mitochondrial encephalomyopathy: correlation of P-31 exercise MR spectroscopy with clinical findings. Radiology 192:223-230
20. Laguno M, Milinkovic A, de Lazzari E, Murillas J, Martinez E, Blanco JL, Lonca M, Biglia A, Leon A, Garcia M, Larrousse M, Garcia F, Miro JM, Gatell JM, Mallolas J (2005) Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patients. Antivir Ther 10:423-429
21. Larsen AI, Aarsland T, Kristiansen M, Haugland A, Dickstein K (2001) Assessing the effect of exercise training in men with heart failure; comparison of maximal, submaximal and endurance exercise protocols. Eur Heart J 22:684-692
22. Larson-Meyer DE, Newcomer BR, Hunter GR, Hetherington HP, Weinsier RL (2000) 31P MRS measurement of mitochondrial function in skeletal muscle: reliability, force-level sensitivity and relation to whole body maximal oxygen uptake. NMR Biomed 13:14-27
23. Mariotti C, Uziel G, Carrara F, Mora M, Prelle A, Tiranti V, DiDonato S, Zeviani M (1995) Early-onset encephalomyopathy associated with tissue-specific mitochondrial DNA depletion: a morphological, biochemical and molecular-genetic study. J Neurol 242:547-556
24. Matthews PM, Allaire C, Shoubridge EA, Karpati G, Carpenter S, Arnold DL (1991) In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology 41:114-120
25. Matthews PM, Berkovic SF, Shoubridge EA, Andermann F, Karpati G, Carpenter S, Arnold DL (1991) In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF). Ann Neurol 29:435-458
26. McCully KK, Argov Z, Boden BP, Brown RL, Bank WJ, Chance B (1988) Detection of muscle injury in humans with 31-P magnetic resonance spectroscopy. Muscle Nerve 11:212-216
27. Mizuno M, Secher NH, Quistorff B (1994) NMR spectroscopy, rsEMG, and histochemical fiber types of human wrist flexor muscles. J Appl Physiol 76:531-588
28. Nakagawa Y, Ratkevicius A, Mizuno M, Quistorff B (2005) ATP economy of force maintenance in human tibialis anterior muscle. Med Sci Sports Exerc 37:937-943
29. Park JH, Vansant JP, Kumar NG, Gibbs SJ, Curvin MS, Price RR, Partain CL, James AE Jr (1990) Dermatomyositis: Correlative MR imaging and P-31 MR spectroscopy for quantitative characterization of inflammatory disease. Radiology 177:473-479
30. Polagr J, Johnson MA, Weightman D, Appleton D (1973) Data on fibre size in thirty-six human muscles. An autopsy study. J Neurol Sci 19:307-318
31. Quistorff B, Johansen L, Sahlin K (1993) Absence of phosphocreatine resynthesis in human calf muscle during ischemic recovery - glycolysis and glycogenolysis are regulated by factors other than pH, Pi, ADP and AMP during ischaemia. Biochem J 291:681-686
32. Ratkevicius A, Quistorff B (2002) Metabolic costs of force generation for constant-frequency and catchlike-inducing electrical stimulation in human tibialis anterior muscle. Muscle Nerve 25:419-426
33. Schwartz M, Vissing J (2002) Paternal inheritance of mitochondrial DNA. N Engl J Med 347:576-580
34. Tarnopolsky MA, Parise G (1999) Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease. Muscle Nerve 22:1228-1233
35. Taylor DJ, Kemp GJ, Radda GK (1994) Bioenergetics of skeletal muscle in mitochondrial myopathy. J Neurol Sci 127:198-206
36. Vissing J (2002) Mitochondrial myopathies. In: Preedy VR, Peters TJ (eds) Skeletal Muscle: Pathology, Diagnosis and Management of Disease. Chapter 14 London, Greenwich Medical Media Ltd. pp 153-166
37. Vissing J, Salamon MB, Arlien-Soborg P, Norby S, Manta P, DiMauro S, Schmalbruch H (1998) A new mitochondrial tRNA(Met) gene mutation in a patient with dystrophic muscle and exercise intolerance. Neurology 50:1875-1878
38. Wallace DC, Zheng XX, Lott MT, Shoffner JM, Hodge JA, Kelley RI, Epstein CM, Hopkins LC (1988) Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 55:601-610
39. Walker UA, Collins S, Byrne E (1996) Respiratory chain encephalomyopathies: A diagnostic classification. Eur Neurol 36:260-267
40. Wibrand F, Ravn K, Schwartz M, Rosenberg T, Horn N, Vissing J (2001) Multisystem disorder associated with a missense mutation in the mitochondrial cytochrome b gene. Ann Neurol 50:540-543
41. Younkin DP, Berman P, Sladky J, Chee C, Bank W, Chance B (1987) 31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes. Neurology 37:165-169